Home Tags Press
An insulin pill. That’s what Oramed Pharmaceuticals, a small Israeli-based company, hopes to offer millions of diabetics by 2016. “Oral insulin does not exist in the world today, but we are the furthest advanced in getting it into the market,” said Nadav Kidron, CEO of Oramed. “We are just about to start a Phase 2 trial in the United States, which is big news.”
Have you thought about investing in dividend-paying stocks? As the name suggests, these are stocks that pay out a certain percentage of the company’s earnings as a dividend periodically (usually quarterly) to the investor. Recently, dividend-paying stocks have received a good press in publications such as The Wall Street Journal. Have you considered why dividend-paying stocks might be good for you?
Jewish Press' Yishai Fleisher, is joined by Aryeh King, founder and chairman of the Israel Land Fund. Yishai and Aryeh discuss land reclamation in eastern Jerusalem and realistic plans for the expansion of Jerusalem in time for the mass pilgrimages.
Doing my best to copy Sholom Aleichem’s gifted portrayal, and adding a bit on my own, I transformed the downtrodden Jew of galut into a proud pioneer in the Holy Land and a brave fighter for Jewish freedom. It’s a saga that I am sure you and your children will love. And now, thanks to The Jewish Press, it’s free!
The State Dept. press director Patrick Ventrell said, "We’ve seen the reports ... but we do not accept the legitimacy of continued Israeli settlement activity."
12Page 2 of 2